The Commerce Department reverted to its initial decision in an antidumping duty investigation to adjust a Turkish pipe exporter's post-sale price by only one-third of a late delivery penalty in Nov. 2 remand results filed at the Court of International Trade. Submitting the remand following a mandate from the U.S. Court of Appeals for the Federal Circuit reversing a CIT opinion, Commerce also dropped its particular market situation adjustment to the respondent Borusan Mannesmann Boru Sanayi ve Ticaret's costs for the sales-below-cost test (Borusan Mannesmann Boru Sanayi ve Ticaret A.S. v. U.S., CIT Consol. #19-00056).
Court of International Trade activity
Acer America and its repair and service subsidiary joined the massive Section 301 litigation, alleging in a Nov. 1 complaint at the Court of International Trade that the Office of the U.S. Trade Representative ran afoul of the 1974 Trade Act and the 1946 Administrative Procedure Act when it imposed the lists 3 and 4A tariffs on Chinese imports. Acer’s complaint cites tariff exposure to 16 classifications of goods on List 3 and four on List 4A, including for PCs, speakers and projectors. Acer’s law firm is Akin Gump, which crafted the first-filed HMTX Industries-Jasco Products complaint in September 2020 that springboarded the roughly 3,800 nearly identical actions to follow, all seeking to have the tariff rulemakings vacated and the duties refunded with interest. HMTX-Jasco is now the designated sample case, and Akin Gump’s deadline is Nov. 15 for filing papers supporting its Aug. 2 motion for judgment on the agency record. It’s the final entry on the court’s April 13 scheduling order. Oral argument is expected next, possibly as soon as December (Acer America Corporation v. U.S., CIT #21-00575).
Antidumping review respondent Hyundai Steel Co. "shifted its narrative" when answering a supplemental questionnaire from the Commerce Department on remand from the Court of International Trade, U.S. Steel argued in comments on the remand results. Arguing against Commerce's decision to drop its adverse facts available finding over a discrepancy between two product codes, U.S. Steel argued that Commerce mistook the court's decision as "somehow requiring Commerce to blind itself to Hyundai's troubling history of failing to cooperate to the best of its ability."
The Court of Appeals for the Federal Circuit remanded in part and sustained in part the Court of International Trade's opinion in a Nov. 3 decision amid a customs battle over bicycle seats. The Federal Circuit found the trade court erred in approving CBP's use of "bypass entries" to show the established classification treatment of the bicycle seat imports. However, the three-judge panel at the Federal Circuit upheld CIT's finding of no de facto established and uniform practice. The plaintiff, Kent International, had argued that such a practice existed based on CBP's liquidation of its entries, and the entries of third parties, under its preferred Harmonized Tariff Schedule subheading.
The following lawsuits were recently filed at the Court of International Trade:
Ball bearings importer Wermex filed a complaint at the Court of International Trade Oct. 29, contesting CBP's reliquidation of its entries after being erroneously covered by injunctions, when the entries should have been deemed liquidated or been liquidated in line with the final results of the relevant AD review.
The Commerce Department again dropped its particular market situation adjustment to the sales-below-cost test in an antidumping review, despite continuing to find that a PMS existed during the review. Dropping the adjustment in Oct. 29 remand results at the Court of International Trade, Commerce said it fulfilled the terms of its voluntary remand request in the case, explaining that the court ruled in other cases that the agency is not allowed to make such an adjustment when finding normal value (NEXTEEL Co., Ltd. v. United States, CIT #20-03868).
Three Court of International Trade cases filed by Janssen Ortho should be assigned to Judge Jennifer Choe-Groves and stayed, Janssen argued in an Oct. 27 brief at CIT now that the U.S. Court of Appeals for the Federal Circuit has issued its opinion in the appeal. In April, the Federal Circuit upheld Choe-Groves' decision that the active pharmaceutical ingredient imported by Janssen in one of its HIV medications was eligible for duty-free treatment (see 2104260034). The API was darunavir ethanolate (Janseen Ortho LLC v. United States, CIT #13-00052, #14-00094, #14-00198).
The Court of International Trade on Oct. 29 granted the Commerce Department's request for a voluntary remand in an antidumping duty case, so the agency can review whether it was appropriate to rely on supplemental questionnaire responses, seeing as it couldn't conduct an on-site verification. The court found that Commerce gave enough evidence of "substantial and legitimate" concerns to remand the case and further explore whether the "novel legal approach that Commerce took during the [COVID-19] pandemic" can be properly supported. The court also noted that on-site verification may now be possible given eased travel restrictions (Ellwood City Forge Company, et al. v. United States, CIT #21-00007).
CBP properly found that pencil importer Royal Brush Manufacturing evaded antidumping duties on cased pencils from China, the Court of International Trade held in an Oct. 29 opinion. Chief Judge Mark Barnett upheld CBP's determination after initially remanding the case for not having provided adequate public summaries of business confidential information. Finding that on remand, CBP cleared this hurdle and that the summaries did not violate Royal Brush's due process rights, Barnett upheld the evasion finding.